IDiyas

For the Inventor, By the Inventor

West Lafayette, IN, United States of America

David Thomas Jonaitis

USPTO Granted Patents = 22 

 

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 30(Granted Patents)


Location History:

  • Brookstone, IN (US) (2011)
  • West Lafayette, IN (US) (2008 - 2015)
  • Waltham, MA (US) (2015)
  • Brookston, IN (US) (2013 - 2024)

Company Filing History:

goldMedal7 out of 549 
 
Celgene Corporation
 patents
silverMedal4 out of 5 
 
Canna Chemistries LLC
 patents
bronzeMedal3 out of 1,500 
 
Astrazeneca Ab
 patents
4. 2 out of 9 
 
Astrocyte Pharmaceuticals, Inc.
 patents
5. 2 out of 415 
 
Nektar Therapeutics
 patents
6. 1 out of 1 
 
Mutual Pharamaceutical Company, Inc.
 patent
7. 1 out of 16 
 
Aurigene Oncology Limited
 patents
8. 1 out of 92 
 
Acadia Pharmaceuticals Inc.
 patents
9. 1 out of 29 
 
Novartis Pharma Ag
 patents
10. 1 out of 100 
 
Idenix Pharmaceuticals, Inc.
 patents
11. 1 out of 23 
 
Takeda Pharmaceuticals U.s.a., Inc.
 patents
where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...
Loading Chart...
22 patents (USPTO):
1. 12358874 - Crystalline salts of psilocin (2025-07-15),
2. 12090137 - Solid Δ-tetrahydrocannabinol (Δ-THC) compositions (2024-09-17),
3. 11970447 - Crystalline salts of psilocin (2024-04-30),
4. 11866420 - Hydrochloride salt forms of a sulfonamide structured kinase inhibitor (2024-01-09),
5. 11827600 - Crystalline forms of trofinetide (2023-11-28),
6. 11478447 - Solid Δ-tetrahydrocannabinol (Δ-THC) compositions (2022-10-25),
7. 11406629 - Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2022-08-09),
8. 11324769 - Polymorphic compounds and uses thereof (2022-05-10),
9. 10835522 - Solid forms comprising 4-amino-2-(2,6- dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2020-11-17),
10. 10765693 - Polymorphic compounds and uses thereof (2020-09-08),
11. 10376503 - Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2019-08-13),
12. 9974780 - Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2018-05-22),
13. 9968627 - Solid forms comprising 4-amino-1-β-D-ribofuranosyl-1,3,5-triazin-2(1H)-one and a coformer, compositions and methods of use thereof (2018-05-15),
14. 9808450 - Solid forms comprising 3-(4-amino-1-OXO-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and a coformer, compositions and methods of use thereof (2017-11-07),
15. 9695146 - Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2017-07-04),

Title: David Thomas Jonaitis - A Pioneer in Inventions

Introduction:

David Thomas Jonaitis is a distinguished inventor based in West Lafayette, IN (US). Known for his unwavering passion for innovation and problem-solving, he has made significant contributions to the industry with his inventive spirit.

Latest Patents:

- Solid Δ-tetrahydrocannabinol (Δ-THC) compositions: Jonaitis' invention focuses on a solid Δ-THC composition beneficial for pharmaceutical or nutraceutical purposes. The composition involves a molar ratio of Δ-THC to powder former to create a flowable Δ-THC powder, opening new avenues for medication administration and incorporation into food and beverage products.

- Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer: This patent reveals solid forms including 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, offering novel pharmaceutical compositions with diverse applications for treating various disorders.

Career Highlights:

With an impressive portfolio of 17 patents, David Thomas Jonaitis has showcased his innovative prowess in the realm of inventions. His dedication to creating groundbreaking solutions has led to patents that revolutionize the pharmaceutical and nutraceutical industries.

Collaborations:

Throughout his career, Jonaitis has collaborated with esteemed companies such as Celgene Corporation and AstraZeneca AB. His partnerships with professionals like G Patrick Stahly and Ho-Wah Hui have further enriched his inventive journey, fostering a culture of innovation and knowledge exchange.

Conclusion:

David Thomas Jonaitis stands as a true pioneer in the world of inventions, consistently pushing boundaries and reshaping industries with his innovative creations. His patents not only demonstrate his technical expertise but also underscore his commitment to advancing healthcare and pharmaceutical innovation. As a respected figure in the industry, Jonaitis continues to inspire future generations of inventors with his remarkable contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…